Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours – reply by Shamash, J
1258 Letters to the Editor
British Journal of Cancer (2000) 83(9), 1255–1259 © 2000 Cancer Research Campaign
0 500 1000 1500 2000 2500 3000
Days
100
80
60
40
20
0
S
u
r
v
i
v
a
l
(
%
)
100
80
60
40
20
0
0 500 1000 1500 2000 2500
Days
S
u
r
v
i
v
a
l
(
%
)
0
0
500 1000 1500 2000 2500 3000
20
40
60
80
100
Days
S
u
r
v
i
v
a
l
 
(
%
)
0 500 1000 1500 2000 2500 3000
Days
100
80
60
40
20
0
S
u
r
v
i
v
a
l
(
%
)
0 500 1000 1500 2000 2500 3000
Days
100
80
60
40
20
0
S
u
r
v
i
v
a
l
(
%
)
0
0
500 1000 1500 2000 2500 3000
20
40
60
80
100
Days
S
u
r
v
i
v
a
l
 
(
%
)
Figure 2 (A) The survival for 81 patients with metastatic TGCT according to the initial postsurgical S-LD-1 (—— = 39 patients with S-LD-1 < 112 U L–1,
– – = 37 with S-LD-1 112–1120 U l–1, and – . – = five with S-LD-1 > 1120 U l–1). (B) The survival according to S-hCG (—— = 39 patients with S-hCG < 30 IU l–1,
– – = 33 with S-hCG 30–4999 IU l–1, - - - = four with S-hCG 5000–50 000 IU l–1, - - - = five with S-hCG > 50 000 IU l–1). (C) The survival according to the risk
groups of the IGCCCG classification (—— = 49 patients with a good prognosis, —— = 16 with an intermediate prognosis, and - - - = 16 with a poor prognosis).
(D) The survival according to S-AFP (—— = 50 patients with S-AFP < 24 µ g l–1, —— = 26 with S-AFP 24–999 µ g l–1, - - - = four with S-AFP 1000–10 000 µ g l–1,
- - - = one with S-AFP > 10 000 µ g l–1. (E) The survival according to the concomitantly normal and raised levels of S-LD-1 and S-LD (—— = 31 patients with
normal values of S-LD-1 and S-LD, — — = eight with a normal value of S-LD-1 and a raised S-LD, and - - - = 42 with a raised S-LD-1 (with or without a raised
S-LD)). (F) The survival according to the S-LD-1/S-LD ratio (—— = 73 patients with an S-LD-1 ratio < 0.375, and – – = eight with a ratio > 0.375)
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Serum lactate dehydrogenase isoenzyme 1 as a
prognostic predictor for metastatic testicular germ cell
tumours – reply
Sir
von Eyben et al describe their experience of splitting total LDH
into its various isoenzymes and have identified LDH isoenzyme 1
(S-LD-1) as having prognostic significance in untreated patients
with metastatic germ cell tumours. The evidence they present
is clearly impressive and S-LD-1 appears to be able to identify
patients with a poor outcome as effectively as the IGCCCG speci-
fication or serum HCG alone.Letters to the Editor 1259
British Journal of Cancer (2000) 83(9), 1255–1259 © 2000 Cancer Research Campaign
We agree that validation of their findings with a larger set of
patients would be useful and also feel that the prognostic role of
S-LD-1 in patients who relapse should also be assessed to see if
its predictive role in this setting is maintained.
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